secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001159036-25-000036
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme appoints Cortney Caudill as COO; base salary $600K, equity award $500K
-------------------------------------------------------------------------------

- Cortney Caudill appointed SVP, COO effective Oct 1, 2025; previously SVP, Chief Operations Officer since Oct 2023.
- Annual base salary set at $600,000; eligible for executive incentive plans with 2025 bonus target of 50% of salary.
- Receives $500K equity award (50% stock options, 50% RSUs) vesting over four years.
- No family relationships or material interests in any transactions with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/0001159036-25-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903625000036/halo-20251001.htm
  HTML page:      https://secwatch.observer/filing/0001159036-25-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer